Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Major

Showing results (171-180 of 217) with videos related to

Pageof 22
Sort By:
Clinical Microbiology Reviews|July 6, 2012
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainMichael W Ferenczy, Leslie J Marshall, Christian D S Nelson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 13, 2005
Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremiaDaniel L Bohl, Gregory A Storch, Caroline Ryschkewitsch, et al.
Annals of Neurology|June 9, 1999
Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathyC T Yiannoutsos, E O Major, B Curfman, et al.
Clinical and Diagnostic Laboratory Immunology|March 11, 2003
Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassaysRaphael P Viscidi, Dana E M Rollison, Emma Viscidi, et al.
The Lancet. Neurology|April 17, 2024
Biomarkers for progressive multifocal leukoencephalopathy: emerging data for use of JC virus DNA copy number in clinical trialsIrene Cortese, Gina Norato, Patrick R Harrington, et al.
Therapeutic Advances in Hematology|October 12, 2023
Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case reportFieke W Hoff, John Rolwes, Paula A Hardeman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2003
Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumorsDana E M Rollison, Kathy J Helzlsouer, Anthony J Alberg, et al.
Cell Death and Differentiation|April 23, 2016
p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegenerationC Turnquist, I Horikawa, E Foran, et al.
Neurology|February 19, 2000
AIDS- and non-AIDS-related PML association with distinct p53 polymorphismC Power, J G Gladden, W Halliday, et al.
Neurotoxicity Research|January 23, 2010
Differences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicityE A Eugenin, J E King, J E Hazleton, et al.
Pageof 22

Showing results (171-180 of 217) with videos related to

Sort By:
Pageof 22
Clinical Microbiology Reviews|July 6, 2012
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brainMichael W Ferenczy, Leslie J Marshall, Christian D S Nelson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 13, 2005
Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremiaDaniel L Bohl, Gregory A Storch, Caroline Ryschkewitsch, et al.
Annals of Neurology|June 9, 1999
Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathyC T Yiannoutsos, E O Major, B Curfman, et al.
Clinical and Diagnostic Laboratory Immunology|March 11, 2003
Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassaysRaphael P Viscidi, Dana E M Rollison, Emma Viscidi, et al.
The Lancet. Neurology|April 17, 2024
Biomarkers for progressive multifocal leukoencephalopathy: emerging data for use of JC virus DNA copy number in clinical trialsIrene Cortese, Gina Norato, Patrick R Harrington, et al.
Therapeutic Advances in Hematology|October 12, 2023
Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case reportFieke W Hoff, John Rolwes, Paula A Hardeman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2003
Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumorsDana E M Rollison, Kathy J Helzlsouer, Anthony J Alberg, et al.
Cell Death and Differentiation|April 23, 2016
p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegenerationC Turnquist, I Horikawa, E Foran, et al.
Neurology|February 19, 2000
AIDS- and non-AIDS-related PML association with distinct p53 polymorphismC Power, J G Gladden, W Halliday, et al.
Neurotoxicity Research|January 23, 2010
Differences in NMDA receptor expression during human development determine the response of neurons to HIV-tat-mediated neurotoxicityE A Eugenin, J E King, J E Hazleton, et al.
Pageof 22